2021 / 02

Next Paper
DOI: 10.47183/mes.2021.011

ORIGINAL RESEARCH

Evaluation of efficacy of the amino acid-peptide complex administered intragastrically to golden hamsters experimentally infected with SARS-CoV-2

Laptev DS1, Protasova GA1, Petunov SG1, Radilov AS1, Chepur SV2, Gogolevskiy AS2, Myasnikov VA2, Tyunin MA2, Smirnova AV2
About authors

1 Research Institute of Hygiene, Occupational Pathology and Human Ecology Leningrad Region, Russia

2 State Research and Testing Military Medicine Institute under the Ministry of Defense of the Russian Federation, St. Petersburg, Russia

Correspondence should be addressed: Denis S. Laptev
stancija Kapitolovo, stroenie 93, r.p. Kuzmolovsky, Vsevolozhsky r., 188663; ur.liam@nedpal

About paper

Author contribution: Laptev DS, Protasova GA, Myasnikov VA, Tyunin MA, Smirnova AV — experiment, information collection, data processing; Petunov SG — data processing and interpretation; Radilov AS — scientific concept, consulting; Chepur SV — experiment organization, COVID-19 in vivo model development; Gogolevskiy AS — experiment organization. All authors participated in the manuscript authoring and editing.

Compliance with ethical standards: the study was conducted in conformity to the provisions of the European Convention for the Protection of Vertebrate Animals used for Experimental and other Scientific Purposes.

Received: 2021-05-21 Accepted: 2021-06-06 Published online: 2021-06-16
|
  1. Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020; 579: 270–73.
  2. Kogan EA, Berezovskij YuS, Procenko DD, Bagdasarjan TR, Grecov EM, Demura SA, i dr. Patologicheskaja anatomija infekcii, vyzvannoj SARS-COV-2. Cudebnaja medicina. 2020; 2: 8–30. Russian.
  3. Heinz FX, Stiasny K. Profiles of current COVID-19 vaccines. Wien Klin Wochenschr. 2021; 1–13. DOI: 10.1007/s00508-02101835-w.
  4. DeFrancesco L. COVID-19 antibodies on trial. Nat Biotechnol. 2020; 38: 1242–52. DOI: 10.1038/s41587-021-00813-x.
  5. Brouwer JM, Caniels TG, Straten K, Snitselaar JL, Aldon Y, Bangaru S, et al. Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability. Science. 2020; 369: 643–50.
  6. Tortorici A, Beltramello M, Lempp FA, Pinto D, Dang HV, Rosen LE. Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms. Science. 2020; 370: 950–7. DOI: 10.1126/science.abe3354.
  7. Karkischenko VN, Pomytkin IA, Skvortsova VI. The Opioidergic System of Immune Cells: A New Pharmacological Target in the Therapy of “Cytokine Storm”. Journal Biomed. 2020; 16 (4): 14– 23. Russian.
  8. Sia SF, Yan LM, Chin AH, Fung K, Choy KT, Wong AL, et al. Pathogenesis and transmission of SARSCoV-2 in golden hamsters. Nature. 2020; 583 (7818): 834–8. DOI: 10.1038/ s41586-020-2342-5.
  9. Imaia M, Iwatsuki-Horimotoa K, Hattab M, Loeberc S, Halfmannb PJ. Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development. PNAS. 2020; 117 (28): 16587–95. DOI: 10.1073/pnas.2009799117.
  10. Chan JF, Zhang AJ, Yuan S, Poon VK, Chan CC, Lee AC, et al. Simulation of the clinical and pathological manifestations of Coronavirus Disease 2019 (COVID-19) in golden Syrian hamster model: implications for disease pathogenesis and transmissibility. Clin Infect Dis. 2020; 71 (9): 2428–46. DOI: 10.1093/cid/ciaa325.
  11. Laptev DS, Petunov SG, Nechaykina OV, Bobkov DV, Radilov AS. Using experimental ex vivo models to develop COVID-19 pathogenetic therapy and complications prevention agents. Extreme Medicine. 2020; (4): 6–12. DOI: 10.47183/mes.2020.020. Russian.
  12. Reed LJ, Muench H. A simple method of estimating fifty percent endpoints. Am J Hygiene. 1938; 27: 493–7.
  13. Rybakova AV, Makarova MN. Sanitarnyj kontrol' jeksperimental'nyh klinik (vivariev) v sootvetstvii s lokal'nymi i mezhdunarodnymi trebovanijami. Mezhdunarodnyj vestnik veterinarii. 2015; 4: 81– 89. Russian.
  14. Nambulli S, Xiang Y, Tilston-Lunel NL, Rennick LJ, Sang Z, Klimstra WB, et al. Inhalable Nanobody (PiN-21) prevents and treats SARS-CoV-2 infections in Syrian hamsters at ultra-low doses. Sci Adv. 2021; 7 (22): eabh0319. DOI: 10.1126/sciadv. abh0319.
  15. Barnes K, Ingram JC, Porras OH, Barros LF, Hudson ER, Fryer LG, et al. Activation of GLUT1 by metabolic and osmotic stress: potential involve ment of AMP activated protein kinase. J Cell Sci. 2002; 115: 2433–42.
  16. Zabozlaev FG, Kravchenko YeV, Galljamova AR, Letunovskij NN. Patologicheskaja anatomija legkih pri novoj koronavirusnoj infekcii (SOVID-19). Predvaritel'nyj analiz autopsijnyh issledovanij. Klinicheskaja praktika. 2020; 11 (2): 60–76. Russian.
  17. Baum BA, Ajithdoss D, Copin R, Zhou A, Lanza K, Negron N, et al. REGN-CоV2 antibodies prevent and treat SARS-CoV-2 infection in rhesus macaques and hamsters. Science. 2020; 370: 1110–5.
  18. Hartman AL, Nambulli S, McMillen CM, White AG, TilstonLunel NL, Albe JR, et al. SARS-CoV-2 infection of African green monkeys results in mild respiratory disease discernible by PET/ CT imaging and shedding of infectious virus from both respiratory and gastrointestinal tracts. PLoS Pathog. 2020; 16 (9): e1008903. DOI: 10.1371/journal.ppat.1008903.